Rheumatoid Arthritis Clinical Trials in New York

Showing 2781-2800 of 3,596 trials

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

NCT01418001

The purpose of this study is to see the effects, good and/or bad, of the drug combination of gemcitabine, docetaxel and pazopanib on sarcoma. This is a phase Ib-phase II clinical trial. The goal of a phase Ib part of the clinical trial is to confirm a dose of the drugs that is safe. The investigators determine this by closely checking for side effects that the patient may experience.

SarcomaLeiomyosarcomaMalignant Peripheral Nerve Sheath Tumor+2 more

Memorial Sloan Kettering Cancer Center5 participantsStarted Aug 2011

Los Angeles, California, United States • Evanston, Illinois, United States • St Louis, Missouri, United States +1 more locations

COMPLETEDPhase 2< 1 mile

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

NCT01693068

This is a Phase 2, multicenter, randomized, controlled, open-label trial of pimasertib versus dacarbazine aimed to confirm the activity of pimasertib in previously untreated subjects with N-Ras mutated locally advanced or metastatic malignant cutaneous melanoma by comparing the progression-free survival (PFS) of subjects treated with either pimasertib or dacarbazine and by getting a better understanding of the efficacy, safety, pharmacogenomics (PGx) and their relationship with pimasertib exposure.

N-Ras Mutated Locally Advanced or Metastasis Malignant Cutaneous Melanoma

EMD Serono194 participantsStarted Dec 2012

Birmingham, Alabama, United States • Tucson, Arizona, United States • San Francisco, California, United States +98 more locations

Gemcitabine and Docetaxel in Combination With Pazopanib (Gem/Doce/Pzb) for the Neoadjuvant Treatment of Soft Tissue Sarcoma (STS)

Phase II Trial of Pimasertib Versus Dacarbazine in N-Ras Mutated Cutaneous Melanoma

Rheumatoid Arthritis Trials in Other Cities

Medication Adherence in Children Who Had a Liver Transplant

Safety and Efficacy of Cognitive Behavior Therapy for People With Post-traumatic Stress and Cardiovascular Illness

Cognitive-Behavioral Therapy and Escitalopram for Generalized Anxiety Disorder(GAD)

Dexamethasone as an Immediate Intervention

AA4500 (XIAFLEX™, Proposed Name) in the Treatment of Dupuytren's Contracture

A Multi-center Clinical Trial of the Misago™ Self-Expanding Stent System for Superficial Femoral Artery

Randomized Switch Study From Hydroxyurea to Ruxolitinib for RELIEF of Polycythemia Vera Symptoms: The Relief Study

Study to Assess Best Corrected Visual Acuity (BCVA) in Patients With Neovascular Age-Related Macular Degeneration (AMD) Who Are Administered VEGF Trap-Eye (Intravitreal Aflibercept Injection)

Efficacy of Panobinostat in Patients With Relapsed and Bortezomib-refractory Multiple Myeloma

3rd Party LMP1/2-Specific Cytotoxic T Lymphocytes for EBV-Associated Lymphoma

Palifermin in Lessening Oral Mucositis in Patients Undergoing Radiation Therapy and Chemotherapy for Locally Advanced Head and Neck Cancer

Trial of IMO-3100 in Patients With Moderate to Severe Plaque Psoriasis

Bevacizumab and Irinotecan in Treating Young Patients With Recurrent, Progressive, or Refractory Glioma, Medulloblastoma, Ependymoma, or Low Grade Glioma

Extended Follow-Up After Islet Transplantation in T1D

GP2013 Treatment in Patients With Active Rheumatoid Arthritis, Previously Treated With Rituxan® or MabThera®

Combination Study of Pomalidomide, Marizomib, and Low-Dose Dexamethasone in Relapsed and Refractory Multiple Myeloma

Study of Ozanezumab (GSK1223249) Versus Placebo in the Treatment of Amyotrophic Lateral Sclerosis

Safety Escalating Repeat IV, in Stroke Patients

Other Conditions in New York